<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>A Review of The Role of The Microbiome on Immune Responses and Its Association With Cystic Fibrosis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>75</FirstPage>
			<LastPage>88</LastPage>
			<ELocationID EIdType="pii">3016</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.7</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mahtab</FirstName>
					<LastName>Ghorban Movahed</LastName>
<Affiliation>Department of Microbiology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-1150-818X</Identifier>

</Author>
<Author>
					<FirstName>Ahya</FirstName>
					<LastName>Abdi Ali</LastName>
<Affiliation>Department of Microbiology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-2425-9503</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>09</Month>
					<Day>20</Day>
				</PubDate>
			</History>
		<Abstract>In recent years, the microbiome has been recognized as a key regulator of immune responses. Evidence suggests that changes in the microbiome can lead to chronic disease and even exacerbation of the disease. Impairment of innate immunity resulting from microbial incompatibility may worsen host susceptibility to infection and exacerbate chronic lung diseases. Specific microbes play a key role in improving immune responses and microbial incompatibility is involved in chronic lung diseases such as asthma, chronic obstructive pulmonary disease, and Cystic Fibrosis (CF). CF is an extremely complex disease that results from a gene mutation. Lack of expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) has late complications. Incompatibility in lung microbiota is associated with chronic lung diseases, but it is not determined whether this incompatibility can cause health problems or ineffective regulation of immune response create the disease and its progression. In the CF, due to the deficiency of the immune system, many opportunistic microorganisms, including Pseudomonas. aeruginosa or Staphylococcus aureus are colonized in the patient’s lung and due to an immunodeficiency causedby a defect in the system CFTR, lungs are unable to clear the bacteria that leads to severe pulmonary complications and respiratory and digestive problems in such patients. Therefore, in these patients, the microbiome contributes to dysfunctional immune responses and disease exacerbations. This review summarizes the impact of the microbiome on host immune responses and its relationship with CF to explore the role of the microbiome in causing CF.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Cystic fibrosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Immune response</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Microbiome</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3016_f4633827265824c4ef45cd3bab340a12.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Neutrophils to Lymphocytes Ratio and the Prognosisof the COVID-19 Patients</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>89</FirstPage>
			<LastPage>96</LastPage>
			<ELocationID EIdType="pii">3017</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.2</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mahsa</FirstName>
					<LastName>Taghavi-Farahabadi</LastName>
<Affiliation>Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-4466-889X</Identifier>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Mahmoudi</LastName>
<Affiliation>Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-1515-4841</Identifier>

</Author>
<Author>
					<FirstName>Seyed Mahmoud</FirstName>
					<LastName>Hashemi</LastName>
<Affiliation>Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-1389-5803</Identifier>

</Author>
<Author>
					<FirstName>Saeed</FirstName>
					<LastName>Namaki</LastName>
<Affiliation>Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical
Sciences, Tehran, Iran,</Affiliation>
<Identifier Source="ORCID">0000-0003-0585-1210</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>09</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new pandemic virus, a global concern, and has threatened human health. This virus binds to the Angiotensin-Converting Enzyme 2 (ACE2) that is expressed on different cells, especially on the alveolar cells. So the virus can enter the lung cells and causes respiratory syndromes. In Coronavirus Disease 2019 (COVID-19)  that is caused by SARS-CoV-2, respiratory failure, and acute inflammation is the main cause of death. According to several reports, multiple factors, such as Neutrophils to Lymphocytes Ratio (NLR) have prognostic potentials in COVID-19. This study aims to review this parameter to have a better prediction about the condition of the patients and their treatments. According to this review, the NLR ratio that is related to the innate immune responses and inflammation can be helpful in the discrimination of severe from non-severe cases of COVID-19 patients.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Coronavirus Disease 2019 (COVID-19)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SARS-CoV-2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Neutrophils to Lymphocytes Ratio (NLR)</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3017_0d669e6c6d2874b97e9a3c23c03fbc36.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>A New Approach to Monitoring and Evaluation of Cecal Ligation and Puncture Sepsis Model</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>97</FirstPage>
			<LastPage>106</LastPage>
			<ELocationID EIdType="pii">3027</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.1</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Arezou</FirstName>
					<LastName>Khosrojerdi</LastName>
<Affiliation>Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-7070-3305</Identifier>

</Author>
<Author>
					<FirstName>Sara</FirstName>
					<LastName>Soudi</LastName>
<Affiliation>Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Ahmad</FirstName>
					<LastName>Zavaran Hosseini</LastName>
<Affiliation>Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-4078-110X</Identifier>

</Author>
<Author>
					<FirstName>Seyed Mahmoud</FirstName>
					<LastName>Hashemi</LastName>
<Affiliation>Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-1389-5803</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>06</Month>
					<Day>23</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background&lt;/strong&gt;: Sepsis is a systemic inflammatory disease in response to the pathogens that leads to vital organ failures the failure of vital organs. Appropriate animal models should be developed to measure the effectiveness of therapeutic methods. Cecal Ligation and Puncture (CLP) is the most widely used methods of creating the sepsis model. Some variables interfere in the creation of the CLP model which terminated to result in an unrepeatable dynamic of the inflammatory responses. The current research, suggests presents the simultaneous study of inflammatory responses in serum and liver as a criterion for determining the inflammatory status of the CLP model. &lt;br /&gt;&lt;strong&gt;Materials and Methods&lt;/strong&gt;: CLP model was induced in 15 female C57bl/6 mice. IL-6, TNF-α, IL-10, and TGF-β1 cytokines levels were measured at 24, 48, and 72 hours after CLP induction in both serum and liver tissue by ELISA method. Serum levels of liver enzymes were analyzed by the clinical chemistry analyzer. All studies were performed in healthy mice as well. The results were reported as Mean±SD.&lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: The levels of IL-10 and TGF- β1 in the liver is were significantly (P≤0.05) higher than serum. The production of IL-10 and TGF- β1 in the serum and liver reaches its maximum at peaked 24 and 72 hours after CLP induction. The level of TNF-α in the liver is was significantly (P≤0.05) higher than serum with a maximum production 24 hours after CLP induction.&lt;br /&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: Serum is not a good representative of the inflammatory condition in sepsis. Therefore, it is suggested that local inflammatory responses be considered in evaluating the model, and the determination of drug efficacy.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Cecal ligation and puncture</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sepsis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Inflammation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cytokine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Liver</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3027_61e94c2ff79b97c3fcb512a068e36d81.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Immunopotentiotor Effect of α-Tocopherol on Cytokine Expression in the Lymphocytes in the Elderly People</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>107</FirstPage>
			<LastPage>114</LastPage>
			<ELocationID EIdType="pii">3028</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.4</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Atifeh</FirstName>
					<LastName>Darabi</LastName>
<Affiliation>Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-0947-0669</Identifier>

</Author>
<Author>
					<FirstName>Setareh</FirstName>
					<LastName>Haghighat</LastName>
<Affiliation>Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-6605-5245</Identifier>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Mahdavi</LastName>
<Affiliation>Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-4478-5957</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>06</Month>
					<Day>27</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background&lt;/strong&gt;: Aging is associated with attenuation of immune responses. Studies show that old people are vulnerable to infectious diseases such as influenza. α-Tocopherol as an immunomodulator affects immune responses. In the present study, the effect of α-tocopherol, on lymphocyte responses i.e. interferon-gamma (IFN-γ), Tumor Necrosis Factor-alpha (TNF-α), and nuclear factor-κB (NF-κB)  in elderly individuals was evaluated. &lt;br /&gt;&lt;strong&gt;Materials and Methods&lt;/strong&gt;: Heparinized blood samples were prepared from 10 elderly individuals (n=10, age &gt;80 years) as the experimental group and 10 young individuals (n= 10, 20-40 years) as the control group. The separated Peripheral Blood Mononuclear Cells (PBMCs) of aged and young individuals were used for treatment with 2 μg/mL of α-tocopherol and 2 μg/mL of Purified Protein Derivative (PPD) after 12 and 24 h incubation period. After isolation of total RNA and synthesize of cDNA, the gene expressions of IFN-γ, TNF-α, and NF-κB were evaluated by real-time PCR method. β-Actin gene was considered as the internal control gene. &lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: Results showed that treatment with α-tocopherol increased the IFN-γ expression in old and young lymphocyte groups. The mRNA level of NF-κB increased in the PPD group after 12 h in both old and young groups (p &lt;0.05). There were no alterations in TNF-α expression in both groups.&lt;br /&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: It seems that α-tocopherol is effective in the promotion of cytokine responses in old individuals and may be useful as a supplement for improving the immune system of elderly people.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">α-tocopherol</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Aging</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lymphocyte responses</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nuclear factor-κB  (NF-κB)</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3028_b0f69b4d559ac14d71f717d271dc8dbd.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Assessment of Antitumor Activity of Vinca herbacea on Human Ovarian Cancer Cell Line</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>115</FirstPage>
			<LastPage>126</LastPage>
			<ELocationID EIdType="pii">3030</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.6</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Somayeh</FirstName>
					<LastName>Dehghanipour</LastName>
<Affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-1791-9852</Identifier>

</Author>
<Author>
					<FirstName>Sara</FirstName>
					<LastName>Saadatmand</LastName>
<Affiliation>Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-9375-0542</Identifier>

</Author>
<Author>
					<FirstName>Nasim</FirstName>
					<LastName>Hayati Roodbari</LastName>
<Affiliation>Immunotherapy Group, Institute of Pharmaceutical Sciences, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-5942-5770</Identifier>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Mahdavi</LastName>
<Affiliation>Department of Immunology, Pasteur Institute of Iran, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-4478-5957</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>03</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background&lt;/strong&gt;: It seems that Vinca. herbacea has an anti-tumor effect. Here, the immunotherapeutic effect of this compound is assessed against human ovarian cancer (SKOV3) cells because of the high incidence of this tumor in women. &lt;br /&gt;&lt;strong&gt;Materials and Methods&lt;/strong&gt;: The cytotoxic activity of V. herbacea extract against human ovarian cancer (SKOV3) cells was determined by MTT assay. The apoptosis-inducing potential of V. herbacea extract was investigated using the FITC-V Annexin kit. The Matrigel invasion assay was used to investigate the ability of V. herbacea extract in reducing ovarian cancer cells invasion. Real-time PCR using specific primers was performed to investigate the expression of angiogenesis (VEGFR1, VEGFR2, and VEGF-A), apoptosis (Bcl-2 and Bax), and metastasis (MMP2 and MMP9) genes. &lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: V. herbacea caused a significant cytotoxic effect against human ovarian cancer cells in a dose-dependent manner. V. herbacea induced apoptosis in SKOV3 cells through caspase-3 activation and an increase in the expression ratio of Bax/Bcl-2. V. herbacea inhibited cancer cells’ angiogenesis, which was evident by the significant reduction in the expression of angiogenesis-related genes, including VEGF, VEGFR-1, and VEGFR-2. Besides, V. herbacea inhibited cancer cell adhesion and invasion. &lt;br /&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: V. herbacea extract elicits a robust cytostatic effect in SKOV3 cells by modulating the activity and or the expression of proteins regulating the process of cellular apoptosis, adhesion invasion, and angiogenesis.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Vinca herbacea extract</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ovarian cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Angiogenesis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Apoptosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Antitumor</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3030_a7aa0a390d8ef22c97ab681d43f18895.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Lactobacillus Acidophilus Cytotoxicity Effect and Apoptosis in Human Bladder Carcinoma Cells: An In Vitro Study</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>127</FirstPage>
			<LastPage>134</LastPage>
			<ELocationID EIdType="pii">3032</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.3</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Faeghe</FirstName>
					<LastName>Taheri</LastName>
<Affiliation>Department of Microbiology, College of Sciences, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0001-8622-9938</Identifier>

</Author>
<Author>
					<FirstName>Elham</FirstName>
					<LastName>Moazamian</LastName>
<Affiliation>Department of Microbiology, College of Sciences, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-4445-3971</Identifier>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Mahdavi</LastName>
<Affiliation>Recombinant Vaccine Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-4478-5957</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>02</Month>
					<Day>23</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction&lt;/strong&gt;: Anticancer effects of Lactobacillus acidophilus, as a probiotic bacterium, have been indicated in several studies. There are common therapeutic options for bladder cancer treatment; however, their side effects and recurrence of disease are considerable. Therefore, complementary medication is essential and it must be safe and effective. In the present research, we assessed the anti-tumor activity of Lactobacillus acidophilus (LB) on the bladder cancer cell line by evaluating the apoptosis mechanism.&lt;br /&gt;&lt;strong&gt;Materials and Methods&lt;/strong&gt;: EJ138 bladder cancer cell line was provided and the cytotoxicity level of LB was evaluated with various concentrations after 24, 48, and 72 h. To evaluate the apoptosis effect, the gene expression of Bax, BCL2, and TNF-α was assessed using real-time PCR.&lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: The optimum concentration of the cytotoxicity level was 12.5μg/mL at 24, 48, and 72 h. Bax expression was upregulated in tumor cells treated with LB alone and the mixture of LB and BCG (LB/BCG) as compared to the control group after 24 and 48 h. Also, the mRNA level of TNF-α increased in treated cells with LB and LB/BCG compared to the control group. BCL2 expression did not show a significant difference between experimental groups versus the control group. &lt;br /&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: Our findings showed that LB has a synergistic effect with BCG through increasing apoptotic gene expression and TNF-α cytokine. Besides, at 48 h treatment, the apoptosis effect is more than 24 h. Thus, it seems that the mode of action of LB is time-dependent.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Probiotic bacteria</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Apoptosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bladder cancer</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3032_a5daa2a7e0ca21cf8395e28901a25903.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Shahed University</PublisherName>
				<JournalTitle>Immunoregulation</JournalTitle>
				<Issn>2588_5200</Issn>
				<Volume>3</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>COVID-19 Patients Suffer From DHEA-S Deficiency</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>135</FirstPage>
			<LastPage>144</LastPage>
			<ELocationID EIdType="pii">3033</ELocationID>
			
<ELocationID EIdType="doi">10.32598/Immunoregulation.3.2.5</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mohammad Reza</FirstName>
					<LastName>Vaez Mahdavi</LastName>
<Affiliation>Department of Physiology, Faculty of Medicine, Shahed University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-1490-4364</Identifier>

</Author>
<Author>
					<FirstName>Sussan</FirstName>
					<LastName>Kaboudanian Ardestani</LastName>
<Affiliation>Instiute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-0303-7066</Identifier>

</Author>
<Author>
					<FirstName>Arezou</FirstName>
					<LastName>Rezaei</LastName>
<Affiliation>Institute of Biological Sciences, School of Biology, Damghan University, Damghan, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0001-6486-851X</Identifier>

</Author>
<Author>
					<FirstName>Saeed</FirstName>
					<LastName>Mohammadi</LastName>
<Affiliation>Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Rajabnia Chenary</LastName>
<Affiliation>Defense Health Research Center, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0003-2268-0652</Identifier>

</Author>
<Author>
					<FirstName>Behnaz</FirstName>
					<LastName>Gharegozlou</LastName>
<Affiliation>Department of Immunology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0001-8423-8937</Identifier>

</Author>
<Author>
					<FirstName>Mohammad Mehdi</FirstName>
					<LastName>Naghizadeh</LastName>
<Affiliation>Immunoregulation Research Center, Shahed University, Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0001-5562-103X</Identifier>

</Author>
<Author>
					<FirstName>Tooba</FirstName>
					<LastName>Ghazanfari</LastName>
<Affiliation>Immunoregulation Research Center , Shahed University&amp;amp;lt; Tehran, Iran.</Affiliation>
<Identifier Source="ORCID">0000-0002-1049-7095</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>10</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Background&lt;/strong&gt;: The nervous, endocrine, and immune systems contribute to the response and dynamic adaption to various stresses. Activation of the hypothalamic-pituitary-adrenal axis has been demonstrated in various active critical illnesses. Novel Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a disease with age and gender disparities. &lt;br /&gt;&lt;strong&gt;Materials and Methods&lt;/strong&gt;: In this study, a total of 125 consecutive inpatients with COVID-19 admitted to Imam Khomeini Hospital Complex from February 12, 2020, to April 4, 2020, were enrolled. The severity of patients was classified into three subgroups based on the types of oxygen therapies. Dehydroepiandrosterone Sulfate (DHEA-S) and cortisol levels were measured in serum of inpatients with Siemens kit. &lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: While the increase in cortisol level was not significant in COVID-19 patients, the DHEA-S level and DHEA-S/cortisol ratio significantly decreased in the patients with the increase in severity of the disease.&lt;br /&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: We proposed that the supplementation of DHEA, the precursor of both androgens and steroids, may ameliorate adverse outcomes of COVID-19 disease and improve COVID-19 patients’ ability to survive.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">COVID-19</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">DHEA-S</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">DHEA-S/cortisol</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">DHEA supplementation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Iran</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://immunoreg.shahed.ac.ir/article_3033_f488e5afbf7af3013e0c85cd618863d8.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
